Pharma manufacturer Celgene will pay $280 million to settle allegations they improperly promoted cancer drugs

Posted on

Settlement resolves allegations that Celgene promoted cancer drugs Thalomid, Revlimid for uses not approved by the FDA.

from Healthcarecare Finance News Feed http://www.healthcarefinancenews.com/news/pharma-manufacturer-celgene-will-pay-280-million-settle-allegations-they-improperly-promoted

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s